Forte Biosciences, Inc.
NASDAQ:FBRX
5.6766 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0.006 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.009 | 0 | 0 | 0.009 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.01 | 0.009 | 0.006 | 0.003 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.009 | 0.013 | 0.014 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.01 | -0.009 | 0 | -0.003 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.009 | -0.013 | -0.014 | 0 | 0 | 0 | 0 | 0.009 | 0 | 0 | 0.009 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 5.74 | 4.353 | 3.567 | 6.369 | 7.139 | 4.787 | 2.488 | 1.379 | 1.034 | 0.693 | 1.352 | 5.656 | 3.523 | 3.322 | 3.025 | 3.688 | 1.937 | 1.354 | 7.596 | 0.353 | 0.31 | 0.863 | 15.619 | 12.262 | 12.763 | 10.436 | 8.294 | 7.563 | 6.632 | 6.624 |
| General & Administrative Expenses
| 7.078 | 3.451 | 2.814 | 3.847 | 1.895 | 2.068 | 2.451 | 2.044 | 1.986 | 1.821 | 1.947 | 2.043 | 2.224 | 1.419 | 1.468 | 1.32 | 0.76 | 0.673 | 3.115 | 0.331 | 0.319 | 0.324 | 3.497 | 4.32 | 2.573 | 2.419 | 2.403 | 2.184 | 2.03 | 1.94 |
| Selling & Marketing Expenses
| -0.01 | -0.009 | -0.006 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.439 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 7.068 | 3.442 | 2.808 | 3.847 | 1.895 | 2.068 | 2.451 | 2.044 | 1.986 | 1.821 | 1.947 | 2.043 | 2.224 | 1.419 | 1.468 | 1.32 | 0.76 | 0.673 | 1.676 | 0.331 | 0.319 | 0.324 | 3.497 | 4.32 | 2.573 | 2.419 | 2.403 | 2.184 | 2.03 | 1.94 |
| Other Expenses
| 0.307 | 0.384 | -0.615 | 0.261 | 0.138 | 0.102 | 0.062 | 0.023 | -0.015 | -0.053 | -0.042 | -0.052 | -0.065 | -0.063 | -0.083 | -0.092 | -0.007 | -0.023 | 0 | -0.006 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 12.808 | 7.795 | 6.375 | 10.216 | 9.034 | 6.855 | 4.939 | 3.423 | 3.02 | 2.514 | 3.299 | 7.699 | 5.747 | 4.741 | 4.493 | 5.008 | 2.697 | 2.027 | 9.272 | 0.684 | 0.629 | 1.185 | 19.116 | 16.582 | 15.336 | 12.855 | 10.697 | 9.747 | 8.662 | 8.564 |
| Operating Income
| -12.818 | -7.804 | -6.381 | -10.216 | -9.034 | -6.855 | -4.939 | -3.423 | -3.02 | -2.514 | -3.299 | -7.699 | -5.747 | -4.741 | -4.493 | -5.008 | -34.754 | -2.027 | -9.263 | -0.684 | -0.629 | -1.187 | -19.107 | 1.427 | -15.327 | -12.846 | -10.687 | -9.737 | -8.652 | -8.553 |
| Operating Income Ratio
| 0 | 0 | -1,063.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,029.222 | 0 | 0 | -131.889 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.307 | 0.384 | 0.509 | 0.261 | 0.138 | 0.102 | 0.062 | 0.023 | -0.015 | -0.053 | -0.042 | -0.052 | -0.065 | -0.063 | -0.083 | -0.092 | -32.064 | -0.023 | -1.32 | -0.006 | -0.001 | 0.002 | -0.306 | -0.301 | -0.762 | -0.034 | -0.15 | -0.216 | -0.414 | -0.52 |
| Income Before Tax
| -12.511 | -7.42 | -5.872 | -9.955 | -8.896 | -6.753 | -4.877 | -3.4 | -3.035 | -2.567 | -3.341 | -7.751 | -5.812 | -4.804 | -4.576 | -5.1 | -34.761 | -2.05 | -10.583 | -0.69 | -0.63 | -1.185 | -19.413 | 1.126 | -16.089 | -12.88 | -10.837 | -9.953 | -9.066 | -9.073 |
| Income Before Tax Ratio
| 0 | 0 | -978.667 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,175.889 | 0 | 0 | -131.667 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | -0.034 | 0.114 | -0.003 | -0.009 | -0.102 | 0.006 | -0.023 | 0.015 | 0.053 | 0.042 | 0 | 0 | 0 | 0 | 0 | 32.057 | 0 | 0.001 | -0.684 | -0.217 | -0.426 | 3.208 | -1.509 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -12.511 | -7.42 | -5.872 | -9.955 | -8.896 | -6.651 | -4.883 | -3.377 | -3.05 | -2.62 | -3.341 | -7.751 | -5.812 | -4.804 | -4.576 | -5.1 | -34.761 | -2.05 | -10.583 | -0.69 | -0.63 | -1.185 | -22.621 | 2.635 | -16.089 | -12.88 | -10.837 | -9.953 | -9.066 | -9.073 |
| Net Income Ratio
| 0 | 0 | -978.667 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,175.889 | 0 | 0 | -131.667 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.27 | -0.16 | -0.16 | -0.26 | -0.42 | -0.32 | -0.23 | -0.18 | -0.21 | -0.18 | -0.23 | -0.54 | -0.43 | -0.36 | -0.62 | -0.45 | -9.52 | -0.97 | -5.02 | -0.33 | -0.3 | -0.12 | -0.001 | 1.32 | -8.08 | -6.47 | -0.001 | -5.02 | -5.55 | -9.32 |
| EPS Diluted
| -0.27 | -0.16 | -0.16 | -0.26 | -0.42 | -0.32 | -0.23 | -0.18 | -0.21 | -0.18 | -0.23 | -0.54 | -0.43 | -0.36 | -0.62 | -0.45 | -9.52 | -0.97 | -5.02 | -0.33 | -0.3 | -0.12 | -0.001 | 1.32 | -8.08 | -6.47 | -0.001 | -5.02 | -5.55 | -9.32 |
| EBITDA
| -12.808 | -7.795 | -6.375 | -10.216 | -9.034 | -6.855 | -4.939 | -3.423 | -3.02 | -2.514 | -3.299 | -7.69 | -5.734 | -4.727 | -4.479 | -4.995 | 29.374 | -2.014 | -10.529 | -0.684 | -0.629 | 0.002 | -19.107 | 1.427 | -15.327 | -12.846 | -10.687 | -9.737 | -8.652 | -8.553 |
| EBITDA Ratio
| 0 | 0 | -1,062.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,169.889 | 0 | 0 | 0.222 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |